Meet the team

Our work makes a lifechanging difference to the rare community. This is why we pride ourselves on delivering highquality trainings, events and projects.

We are proud to say that our team has over 20 years of combined experience working in this space.

Say hello to the Beacon team!

Our team continues to thrive due to the generosity and support of the rare disease community. We treasure working with patient groups and collaborators to break down barriers and transform the patient experience. It is extremely rewarding to help patient groups form, grow and professionalise, so no one has to face their rare journey alone.

Our team adheres to Beacon’s founding values by ensuring that every project, training or event is:

 

  • Patient centred
  • Innovative
  • Impact driven
  • Collaborative
  • Positive
  • Personal
Photo of the Beacon team

We want every interaction with us to be positive and personable. Our team is approachable, welcoming and ready to drop everything to help you reach your specific advocacy goals. We’ll be the first to offer our support or point you in the direction of those who are better suited to assist you. We’ll go the extra mile for you, simply because you go the extra mile for your community.

Keep on reading to get to know us better! 

Our staff

Rick Thompson

CEO
Rick joined Beacon in 2015 as the charity’s first Scientific Officer, and became CEO in 2017. He drives the organisation's vision, growth and strategy, as well as leading the charity's drug repurposing and scientific work.

Mary Rose (MayRo) Roberts

Chief Operating Officer
Mary Rose (MayRo) joined Beacon in 2016. As COO, she oversees the strategy, delivery and development of Beacon’s core activities, heads up our Projects Team and plays a key role in the day-to-day running of the charity.

Blayne Baker

Digital Resources Manager
Blayne joined Beacon in 2020, initially as our Marketing and Engagement Manager. In 2023, Blayne moved into her new role where she is responsible for developing and delivering our on-demand and online resources.

Hannah Harvey

Projects Manager
Hannah joined Beacon in 2021 and works within the Projects Team. She leads many of our core activities, including the Patient Group Mentoring Programme, The Student Voice Prize and masterclasses.

Niamh Antrobus

Senior Communications Officer
Niamh joined Beacon in 2023 and oversees the charity's day-to-day communications, including our social media channels, website and newsletters and also coordinates our weekly blog and guest blogs.

Gabriel Ortega Toledo

Senior Projects Officer
Gabriel joined Beacon in 2024 after graduating in Immunology from the University of Edinburgh. He supports the production and development of our educational resources, acting as a key liaison between collaborators and the community.

Elizabeth Proctor

Senior Events Officer
Elizabeth joined Beacon in 2024 and works primarily within the Projects Team. She supports the organisation and delivery of Beacon’s events and assists with community engagement. She also collaborates with the Fundraising and Communications team on impact measurement.

Megan Burley

Senior Scientific Projects Officer
Megan joined Beacon in 2025 having previously worked as a researcher. As part of the Science Team, Megan is involved in two key projects, REMEDi4ALL and Rare Disease Research. Across these projects, she develops and delivers educational materials and training events for patient group leaders and academics

Jeffery SirMoo

Head of Advocowcy
Jeffery (Jeff) joined the charity in 2021 after our Senior Projects Officer, Phil at Beacon - then Findacure - won the Cambridge Independent's 'design a mini moo' competition, run in conjunction with the Cows about Cambridge art trail.

Our trustees

Our team would be lost without the guidance and support of our charity trustees. Our trustee board is comprised of accomplished life sciences professionals and consultants working in the branding, business, communications and healthcare sectors. Our trustees bring a wealth of knowledge and experience to Beacon with many being touched by rare disease personally.

Read their individual bios now to learn more about these exceptional individuals.

Sophie Costello

Chair of Trustees

Read more

Sophie is the founder and CEO of Costello Medical, a consultancy supporting the healthcare sector in the analysis, interpretation and communication of clinical and health economic data.

The company has grown from a team of 2 in 2008 to over 160 staff in 6 offices across 4 countries. In addition to their work for pharmaceutical and public health clients the teams at Costello Medical also work on a pro bono basis for a wide variety of charities.

Sophie lives in Cambridge with her husband and outside work is kept busy caring for her four young children.

Tony Hall

Vice Chair and Co-founder

Read more

Dr Anthony Hall graduated from King’s College London with first class honours in physiology and pharmacology before going on to study medicine at the Royal Free Hospital.

He joined the pharmaceutical industry in 1994 and has significant experience in the clinical and regulatory development of drugs for rare diseases.

He speaks regularly at rare diseases conferences, is author of a number of articles on orphan drugs and is a member of the IRDiRC Working Group on Orphan drug-development and regulatory processes.

Edna Kissman

 

Read more

Edna Kissmann is one of the owners and senior partners in Kissmann Langford, a strategic communications consultancy.

Previously, she served as Assistant Press Secretary to the late Prime Minister Rabin of Israel and as Global Chair of Healthcare Practice and Chief Knowledge Officer at Burson-Marsteller, a major communications company.

She has been a trustee of the Ashoka Fellowship of Social Entrepreneurs and is now a member of the Ashoka Support Network.

Andy Milligan

 

Read more

Andy Milligan is a leading international brand and business consultant and a founding partner of The Caffeine Partnership, which provides ideas, energy and advice to senior managers on business growth and brands.

His experience spans industries as diverse as airlines, financial services, fast-moving consumer goods, telecommunications, sports and leisure and pharmaceuticals. Andy has published five bestselling business books.

Jo Pisani

 

Read more

Jo is a partner at PwC where she leads the UK Pharmaceuticals and Lifesciences business. She advises companies, investors and ministries of health on strategies to grow the Lifesciences industry. She is passionate about public health issues such as dementia, antimicrobial resistance and rare diseases.

She is also a trustee for the UK Dementia Research Institute and advisory board member for MedCity and University of Strathclyde’s CMAC.

She lives in London with her husband and teenage daughter and is passionate about film, cycling and travel.

Our Patient Group Engagement Committee

Our Patient Group Engagement Committee has been helping us keep the patient group voice at the heart of our work since 2017.

Today, it stands as a vital advisory board that helps us to:

  • Keep up to date with the needs and priorities of the rare disease community 
  • Identify new projects
  • Develop our existing events and projects
  • Evaluate our services

Our rotating committee brings their insights, expertise and lived experiences to the table to help ensure that we are meeting the ever-growing needs of our patient group community.

Get to know the members of our 2025 – 2027 Patient Group Engagement Committee now! 

Photo of Chris Bedford Gay

Anthony Brown

Read more

A lifetime’s experience of Charcot-Marie-Tooth disease has motivated Anthony’s interest in the strengths of others living with rare disease.

He’s keen to understand how those individuals interact with healthcare, education, workplaces and other facets of society. As a geneticist who likes to make stuff work, he has spent a career designing and manufacturing genetic testing tools in the Cambridge biotech community.

Now that his children are beginning to leave home, he is investing his spare energy in ‘a cappella’ harmony singing
and riding bicycles.

Photo of Christine Mutena

Clare Sargeant

Read more

Clare Sargeant is Treasurer and Trustee of the CSF Leak Association, having first joined as a patient member in 2017. Prior to experiencing the overwhelming effects of a CSF leak, Clare enjoyed an active early retirement following a successful career as Financial Controller and Company Secretary for a tech start-up.

Her search for answers led to the diagnosis of several rare diseases, revealing stark disparities in care between rare and common conditions. Clare is a passionate advocate for equitable healthcare and she is especially grateful to Beacon for connecting her with inspiring figures across the rare disease community.

Photo of Craig Michell

David Elvy

Read more

David is a retired police officer living in Kent. His daughter, now an adult, has a very rare genetic/metabolic condition called PMM2-CDG (Congenital Disorder of the Glycosylation). There is no current cure (although research is ongoing) and it’s a question of managing the symptoms, which isn’t easy as it’s a bodywide disorder which can affect many organs and systems from head to toe.

Photo of Francesca Wicks

Despina Dinca

Read more

Despina is Charity Manager at Advocacy for Neuroacanthocytosis Patients, supporting individuals, families and carers affected by ultra-rare neuroacanthocytosis (NA) syndromes, neurodegenerative disorders which have no cure and very little therapeutic support.

With over 30 years’ experience in operations, partnerships, and marketing, and 18+ years in health charities, she is passionate about amplifying patient voices, driving collaborative research, and developing initiatives such as international patient registries to improve outcomes for rare disease communities.

Photo of Laurence Woollard

Diana Perry

Read more

As Founder and CEO of the Ectodermal Dysplasia Society, Diana has worked on a full-time voluntary basis since 1996. She is married to Ian and has five children, two of whom are affected by Ectodermal Dysplasia.

Over the years, Diana has gained extensive knowledge and experience of ED. As a parent of two affected children, she brings a unique blend of empathy, compassion, and first-hand understanding to her work – qualities that shape every aspect of her leadership.

Diana is driven by a deep passion to support the ED community and to help individuals and families manage the daily challenges of living with the condition. She is a strong advocate, ensuring people receive the benefits, care, and support they are entitled to—both in education and in the workplace.
She oversees all aspects of the Society's work, including research initiatives and international collaboration, and is in regular contact with families and professionals alike.

Diana is widely recognised as the driving force of the ED community, leading with energy, dedication, and
heart in all that she does.

Photo of Mandy Sellars

Hannah Humphrey

Read more

Hannah is a dedicated advocate for patient-centred research, ethical practice, and accessibility. Her journey began when her daughter’s symptoms went beyond a 22q11 deletion diagnosis, leading the family to join the 100,000 Genomes Project in 2017. After three and a half years, they received a diagnosis of the ultra-rare condition TANGO2.

She now volunteers with TANGO2 UK, supports other families, and sits on ethics boards and patient participant panels as a lived experience expert—championing the inclusion of patient and family voices in every step of the process.

Photo of Michelle Conway

Jenny Carrington-Elson

Read more

Jenny Carrington-Elson is a communications and advocacy Director, specialising in helping communities and stakeholders drive progress against the toughest challenges experienced by people living with a rare disease.

Jenny’s professional experience is focused on human-centred communications that bridge the gap between underserved communities and the health system – turning patient insight into clarity, influence, and action.

Jenny has a drive for strategic campaigning which brings together comms, advocacy and policy-shaping, and her experience has helped patient organisations, clinical leaders and industry create and launch award-winning, insight-driven programmes that drive inclusive access to good care and services.

She is passionate about rare diseases and believes that we’re heading towards a world where our scientific precision and genetic insight will mean that every condition will “become rare”. Working with small patient communities and navigating funding and resourcing challenges to help people live better is a core focus.

As part of her day job, Jenny advises innovative biotechs and the world’s largest pharmaceutical companies on how to build partnerships with rare communities in pursuit of common goals, as well as working closely with NHS bodies, patient organisations themselves, and academia.

Photo of Mileva Repasky

Jess Hobart

Read more

Jess Hobart has been working to improve the quality of life for people with mast cell diseases (MCDs) for more than thirty years. When she was diagnosed with systemic mastocytosis in her early 20s, her doctor advised her to learn to advocate for herself because most other doctors would never have heard of the condition, and that sparked a passion to help others develop those skills, too.

Jess is the chair of The UK Mastocytosis Support Group, which provides direct support for people with MCDs, advocates for their needs within the healthcare system, and fosters research into the conditions. She was also co-chair of the US non-profit now called The Mast Cell Disease Society (TMS).

She has spoken about the patient experience at medical congresses, advised drug companies on design of clinical trials, and presented to parliamentarians about challenges in health technology assessment in rare diseases.

Jess is co-author of articles in leading journals about quality of life and patient experience in people with MCDs. She is a Patient and Public Voice member of the NHS England Clinical Reference Group for Specialised Allergy and Immunology Services and a member of the National Allergy Strategy Group working group on policy,

She holds a master’s degree in public health from The Johns Hopkins University Bloomberg School of Public Health and a master’s degree in public policy from Harvard’s Kennedy School of Government as well as a BA from Swarthmore College.

Photo of Silvia Cerolini

Julie Benson

Read more

Julie has been a qualified advocate within the field of health and social care for over 20 years and has 7 years’ experience working in special education. Julie is also primary carer to her sister who has cerebral palsy which has enabled her to gain lots of experience of working with professionals to ensure the best outcome and experience, from the carers’ perspective.

She joined Rett UK in July 2012, providing to support to those with Rett syndrome, parents/cares and professionals.

Photo of Sue Routledge

Kate Middleton

Read more

Kate Middleton, CEO and Founder of the Wren Project. The Wren Project is a place where people diagnosed with autoimmune disease can talk about the emotional and social impact of their condition, through sessions of active listening with our trained volunteers.

Through focused, consistent listening support we aim to alleviate the emotional turmoil of an autoimmune diagnosis, providing tools for Wrens to successfully navigate their disease and new life.

Kate founded the Wren Project in 2020. Kate lives with lupus, diagnosed when she was 17. Kate began her career as a history teacher in London, becoming Head of History in a school in Hackney. In 2017 Kate moved to Greece where she ran an organisation supporting refugees in camps throughout the Northern region.

In 2019 Kate returned to the UK, working for the Listening Place, a charity that supports suicidal people with face-to-face listening support delivered by volunteers.
The model of support inspired Kate to create the Wren Project. The Wren Project is a place for people to feel supported, listened and valued.

Photo of Suzie Morris

Lara Bloom

Read more

Lara Bloom is President and CEO of The Ehlers-Danlos Society, where she leads global efforts to raise awareness of rare, chronic, and invisible conditions – specializing in Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), and related conditions. She spearheads international medical collaboration, research funding, education, and advocacy.

A passionate leader in patient engagement and global collaboration, Lara was appointed Academic Affiliate Professor of Practice at Penn State College of Medicine in March 2020, marking a decade of work in patient advocacy. She is widely published and a sought-after keynote speaker at conferences, policy forums, academic lectures, and corporate events.

Lara serves as Vice-Chair of the Board of the International Alliance of Patients’ Organizations (IAPO) and is a Board Member of Genetic Alliance UK.
In June 2025, she received the prestigious Made with Patients Award at the Patient Engagement Open Forum (PEOF), honoring her leadership in shaping truly patient- centered global advocacy.

She was also named a 2025 D-30 Disability List Honoree by Diversability, recognizing her as a prominent voice in the disability and rare disease space.

Photo of Tony Thornburn

Lorna Pender

Read more

Dr Lorna Pender is a patient engagement and medical affairs professional with a knack for bringing rare disease voices to the forefront, whether in the NHS wards, the European Parliament, in a publication, or a conference stage.

With over 14 years’ experience spanning acute medicine, global pharma, and biotech, she’s co-created patient programmes, championed early access initiatives, and helped shape rare disease policy.

Known for blending strategic thinking with a warm, collaborative style, Lorna is happiest when connecting communities, bringing hard truths to the forefront, sparking ideas, and making patient partnerships more than just a buzzword.

As a person with lived experience of severe alopecia; a condition that is rare to find an NHS clinical expert, Dr Pender feels very much aligned and understanding with the difficulty in the rare community in finding access to expertise and medicines and this drives her to make a difference every day in her work and in her advocacy.

Photo of Sue Routledge

Mary Collins

Read more

Mary lives with Fibrous dysplasia, and has had 4 surgeries to date to remove excess bone growth.

Inspired by her own experiences, she has completed degrees in Neuroscience, Psychology and Diversity and Inclusion.

Mary is passionate about the patient experience for rare conditions.

Photo of Suzie Morris

Phillippa Farrant

Read more

Phillippa became involved with rare diseases when her son was diagnosed in 1992, with Duchenne Muscular Dystrophy. This threw her into an unknown world, fighting for services, equipment etc – the normal story for most families living with a family member with a rare disease.

Phillippa became involved in the Duchenne Family Support Group, firstly as a volunteer and then as their paid support worker.

She became a trustee at MDUK and did lots of advocacy and Parliamentary meetings trying to change the system and raise awareness of these rare diseases. Over time she became involved with Genetic Alliance and served 6 years on the board as a trustee.

More recently Phillippa has been a patient representative for the Delivery Group of the England Rare Disease Framework, after her son died in 2019, she came out of the neuromuscular world and started a job as an adult support worker at Wolfram Syndrome UK, an even rarer disease.

Photo of Tony Thornburn

Sailaja Maganti

Read more

Sailaja is the Founder and Chair of the Trustee Board of Prurigo Nodularis International, the only global patient-led charity for the rare, debilitating and distressing skin condition, Prurigo Nodularis (itchy, neuro-immune, inflammatory condition). She is also a 20 year veteran of the condition herself.

She has also been a working group member of the Rare Disease Research Network, is a NICE Public Involvement Programme Expert Panel member and a patient expert on both NICE and SMC HTAs. As a Prurigo Nodularis patient expert she also acts as an advisor, consultant and partner.

Sailaja is a passionate and outspoken advocate determined to see those with a rare disease receive the care and dedicated treatments they all need and deserve, on par with patients of mainstream conditions. She wants the hard-earned insights of rare disease patients’, as well as their expertise and experience taken seriously. Sailaja is able to leverage and transfer a deep and broad skill set gained from a lengthy career in the financial services industry to her patient advocacy.

Photo of Sue Routledge

Sarita Edwards

Read more

Sarita Edwards, MHA is the CEO & President at the E.WE Foundation, a global healthcare advocacy organization for families living with Trisomy 18 (Edwards Syndrome) and other rare diseases.

Sarita’s son Elijah was diagnosed in utero with Full Trisomy 18 which began her efforts of advocacy and public policy.

Sarita is an award-winning advocate, global speaker, and host of the Being Rare Podcast. She provides insight on policy initiatives within her home state and across the country. Sarita has more than 20 years of professional experience in Healthcare Administration and is a candidate for her Doctorate in Health Science.

She holds a Bachelor of Science in Health Science, a Masters in Healthcare Administration, and is a nationally certified Mental Health First Aid Instructor. Sarita lives in North Alabama with her husband and three of their five children.

Photo of Suzie Morris

Scott Hutchings

Read more

Fuelled by his daughter Sienna’s CHAMP1 diagnosis and his late father’s battle with rare leukaemia , Scott is a determined advocate.

He founded CHAMP1 UK, joined the boards of the US and EU based foundations, and now serves as a primary point of contact for the CHAMP1 community – acting as a bridge between boards, researchers, clinicians, and families.

His hands-on experience includes managing patient registries, building a research portal , creating materials to inform and support families , organising global conferences , and co-ordinating awareness days.

He joins the Patient Group Engagement Committee with the goal to help other patient groups succeed.

Photo of Tony Thornburn

Sinéad James

Read more

Sinéad James co-founded the CPA Research Foundation in 2020 after her daughter was diagnosed with Cerebral Proliferative Angiopathy (CPA), a rare and incurable brain disease.

As a trustee, she is passionate about bringing hope to families, raising awareness, and driving research that could one day lead to better treatments.

Her work is fuelled by a deep commitment to making a difference for those living with this little-known condition.

Photo of Sue Routledge

Sue Banks

Read more

Sue is currently Secretary and Trustee of GRI-UK, an organisation she helped to found which became a Registered Charity in 2023. She is also a Family Ambassador for CUREGRIN.

She spent her professional career as a nurse and specialised in Occupational Health (working also in Health & Safety, Ergonomics and Health Education), she founded her own OH Consultancy which became a National Company.

In 2016 Sue’s grandson Evan was diagnosed with GRIN1. She has since been fundraising and leaning about GRI Disorders.

Photo of Suzie Morris

Timothy Dreyer

Read more

Dr Timothy Dreyer (PhD) is a rare disease (sclerosteosis) patient and in 2016, as part of his PhD (University of Pretoria, South Africa), started investigating potential treatments for this ultra rare disease.

He has since continued his sclerosteosis research at the Royal Veterinary College, London, with continued support from UCB Pharma.

Timothy is also a committee member of the parent and patient led Rare Bone Disease Foundation in South Africa, where he assists with raising disease awareness and funds for patient support and research.

He often presents his rare disease research at international scientific conferences and has done interviews, television documentaries (BBC and NHK-World) and given talks at the Beacon Rare Showcase events to raise awareness of sclerosteosis.

Outside of research, Timothy is an avid reader, bit of a gamer and enjoys hiking and weekend breakfast runs on his motorcycle.

Photo of Tony Thornburn

Tracey Hammond

Read more

Tracey has been sharing her lived experience with the CAUK community since 2009, after experiencing two brainstem bleeds in her single cavernoma.

Cavernoma is a rare disease, and connecting with others who understand the challenges it brings has been incredibly important to Tracey.

She began volunteering with CAUK in 2010, and in 2019 joined the staff team. Throughout all roles, her focus has always been on supporting their members through peer-to-peer connection, direct support, and working closely with their amazing volunteers.

Tracey is responsible for managing the charity’s volunteer-delivered support services, including its helpline accessible by email and phone, peer-to-peer support, and community meet-ups. She works closely with the Charity Manager to ensure the patient voice is represented in cavernoma-related research.

Photo of Sue Routledge

Tracy Lynch

Read more

Tracy is the main carer for her daughter, who lives with an extreme form of Wolfram Syndrome.

Her diagnosis in 2010 at the age of eight, led Tracy and her husband to start the WSUK support group, which became a registered charity in 2013.

Since then, she has been actively involved in building and running Wolfram Syndrome UK, supporting families, raising awareness, and working closely with researchers and clinicians.

WSUK is now a small team of five, but Tracy remain closely involved in day-to-day operations and patient-facing activities.

Over the past 15 years, she has had the privilege of connecting with families, researchers and healthcare professionals from around the world. Tracy brings both lived experience and practical insight to patient engagement, and is passionate about ensuring that the voices of those affected by rare conditions are heard and valued.